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Abstract 
Rationale: Despite the preferred application of arterial conduits, the greater saphenous vein (SV) remains 
indispensable for coronary bypass grafting (CABG), especially in multi-vessel coronary artery disease (CAD). 
The objective of the present work was to address the role of mechanical forces in the activation of maladaptive 
vein bypass remodeling, a process determining progressive occlusion and recurrence of ischemic heart disease. 
Methods: We employed a custom bioreactor to mimic the coronary shear and wall mechanics in human SV 
vascular conduits and reproduce experimentally the biomechanical conditions of coronary grafting and 
analyzed vein remodeling process by histology, histochemistry and immunofluorescence. We also subjected 
vein-derived cells to cyclic uniaxial mechanical stimulation in culture, followed by phenotypic and molecular 
characterization using RNA and proteomic methods. We finally validated our results in vitro and using a model 
of SV carotid interposition in pigs. 
Results: Exposure to pulsatile flow determined a remodeling process of the vascular wall involving reduction 
in media thickness. Smooth muscle cells (SMCs) underwent conversion from contractile to synthetic 
phenotype. A time-dependent increase in proliferating cells expressing mesenchymal (CD44) and early SMC 
(SM22α) markers, apparently recruited from the SV adventitia, was observed especially in CABG-stimulated 
vessels. Mechanically stimulated SMCs underwent transition from contractile to synthetic phenotype. 
MALDI-TOF-based secretome analysis revealed a consistent release of Thrombospondin-1 (TSP-1), a 
matricellular protein involved in TGF-β-dependent signaling. TSP-1 had a direct chemotactic effect on SV 
adventitia resident progenitors (SVPs); this effects was inhibited by blocking TSP-1 receptor CD47. The 
involvement of TSP-1 in adventitial progenitor cells differentiation and graft intima hyperplasia was finally 
contextualized in the TGF-β-dependent pathway, and validated in a saphenous vein into carotid interposition 
pig model. 
Conclusions: Our results provide the evidence of a matricellular mechanism involved in the human vein 
arterialization process controlled by alterations in tissue mechanics, and open the way to novel potential 
strategies to block VGD progression based on targeting cell mechanosensing-related effectors. 
Key words: coronary artery bypass grafting, vein graft disease, mechanotransduction, Thrombospondin-1, 
arterialization  
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Introduction 
Coronary artery bypass grafting is used in 
cardiac surgery for more than 50 years to combat the 
consequences of coronary artery disease [1-3], a 
pathology with a wide incidence in Western world (> 
1000 cases/ 106 adult people) and rapidly increasing 
in emerging countries – e.g. China [4]. The most 
represented coronary-compatible vessels used in 
CABG are the internal mammary artery (IMA), the 
radial artery (RA) and the SV. The patency of arterial 
grafts is relatively well preserved, while the SV 
conduits are subject to intima hyperplasia 
determining progressive graft occlusion. In a high 
percentage of cases, this requires re-hospitalization 
with graft stenting and, ultimately, re-intervention [1, 
2]. More in details, early vein graft failure due to acute 
thrombosis occurs in as many as 18% of cases. 
Intermediate graft failure (up to 2 years after surgery), 
and late graft failure (> 2 years after surgery), occurs 
in 20% to 50% of cases at 5 years. Finally, by 10 years 
after surgery, 40% of grafts result completely blocked 
and a further 30% have a compromised flow. Even if 
early remodelling of the vein is predictive for later 
graft patency, the aetiology of long-term failure is still 
poorly understood [5]. Initially, both the surgical 
procedure and exposure to high flow and pressure 
compromise the endothelial layer, which induce 
SMCs proliferation [6, 7], changes in matrix 
composition, and thickening/stiffening of the vessel 
wall. This limits the vein’s adaptability to the arterial 
circulation and ultimately leads to clinically apparent 
stenosis [8]. Animal models revealed that occlusion of 
autologous SV grafts is a consequence of neointima 
formation, driven by proliferation and migration of 
SMCs and possibly of adventitial progenitors into the 
intima [9], inducing extracellular matrix (ECM) 
deposition, and formation of a thick neointima [10]. 
The role of mechanical forces in the progression 
of graft failure has been recognized, although the 
nature of cell-based mechanosensing in the vascular 
tissue remains unclear due the difficulty of 
decoupling distinct components in vivo [11, 12]. In 
fact, the existing studies have not yielded conclusive 
results on the effect of mechanical stimulation on SMC 
growth and phenotype, with results depending on 
direction, frequency, duration and modality of the 
stimulus, but also on the origin and initial phenotype 
of the SMCs. For example, cyclic strain of human 
SV-derived SMCs resulted in increased DNA 
synthesis and cell number with a decrease in smooth 
muscle α-actin (αSMA) [13-15], while cells of arterial 
origin showed opposite effects [16, 17]. Ex vivo vessel 
culture systems (EVCSs) and bioreactors to stimulate 
cells mechanically offer the unique possibility to 
investigate the effects of isolated or combined 
mechanical stimuli under well-controlled and repro-
ducible biomechanical and/or metabolic conditions in 
human large vessels. In this framework, the aim of the 
present investigation was to characterize the effect of 
coronary mechanical conditions on molecular 
programming of vein graft disease using an 
integrated tissue/cell biomechanical approach. 
Methods 
Extended Methods are provided in the Methods 
section in the online only Data Supplement. 
Ethics 
The experimental investigation on human- 
derived tissues and cells was approved by the local 
ethical Committee at Centro Cardiologico Monzino, 
IRCCS. Patients were required to sign an informed 
consent. The use of human material was done in 
compliance with the Declaration of Helsinki. The 
main patient characteristics are shown in Table S1. 
Arteriovenous bypass procedures in pigs were 
performed in female Landrace or Large White/ 
Landrace crossbred pigs weighing 20 to 30 kg. All 
animals received humane care in accordance with the 
Home Office Animals (Scientific Procedures) Act of 
1986 and the Guide for the Care and Use of 
Laboratory Animals published by the US National 
Institutes of Health (NIH Publication No. 85- 23, 
revised 1996). For surgery, anaesthesia was induced 
with a single dose of intramuscular ketamine into the 
neck (0.1 mg/Kg ketamine: Ketaset Injection Fort 
Dodge Animal Health Ltd, Southampton, UK). After 
endotracheal intubation, anaesthesia was maintained 
using 2-3% halothane and oxygen, the animals 
ventilating spontaneously throughout. Animals were 
euthanized with 100 mg/Kg intracardiac injection of 
pentobarbitone in a single dose (Euthatal; 200 mg/mL 
pentobarbital sodium, J.M. Loveridge Plc, 
Southampton, UK). 
Tissue/cells mechanical stimulations 
Mechanical stimulations of SV grafts were 
performed using a custom-made bioreactor [18] 
tailored to reproduce the coronary mechanics. Cell 
straining was performed with Flex-Cell system. 
Mechanical stimulation times ranged from 7 to 14 
days for SV grafts and from 1 to 3 days for cells. 
Tissue/cells analyses 
After mechanical stimulation, tissues, cells and 
culture supernatants were prepared and appropri-
ately processed for histological, immunohistochemi-
cal, immunofluorescence, protein/secretome and 
RNA analyses, as already published [19], and 
described in the extended online methods. 
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In vitro cell culture 
Isolation of cells for in vitro experiments was 
performed as previously described [20, 21], using 
immunomagnetic and/or plastic adherence selection. 
Migration experiments were performed using 
Transwell-based assays followed by quantification of 
Crystal-Violet cell staining. 
Molecular analyses 
Tissue/cells RNA and protein content was 
analysed by Q-RT-PCR and Western blotting 
performed with protocols already published [19], 
while the secretome analysis was conducted using a 
MALDI-TOF methods as already described [22]. 
Data representation and statistical analyses 
In all graphs throughout the manuscript, data 
were plotted as mean ± standard error using 
GraphPad Prism 7. A P value < 0.05 was considered 
significant. The type of statistical test employed for 
data comparison is specified in figure legends. As a 
general rule, comparisons between two independent 
samples were performed by unpaired/paired t-test 
(two-tails), while for comparisons between 3 or more 
groups we adopted one-way ANOVA with post-hoc 
comparisons tests. The specification of the number of 
independent samples included in the analyses and the 
type of statistical tests used to compare data are 
specified in the legends to figures. Further details 
about data processing are provided in the online 
methods section. 
Results 
CABG-like hemodynamics induces consistent 
remodeling of human SV wall associated to 
SMCs phenotypic switching 
Our previous contributions showed that 
application of an 80-120 mmHg pulsatile pressure 
regimen determined a change in the SV structure at 7 
days, consisting of a significant thinning of the vessel 
wall, and elevation in cell death by apoptosis and 
enhanced proliferation [18, 19]. These changes were 
less evident in SVs exposed to venous flow (VP), 
characterized by a constant low pressure (5 mmHg). 
Confirming these findings, morphometric analyses of 
SVs treated with coronary flow showed a significant 
thinning of the medial layer (Figure 1A-B). In order to 
demonstrate the specific effects of mechanical forces 
on intima thickening, we compared results obtained 
in the presence of venous or coronary flow/pressure 
patterns with a conventional vein ‘rings’ culturing 
model[23]. Figure S1 and S2 show results of this 
experiment, which demonstrate that in the presence of 
coronary flow-pressure pattern intima thickening 
does not occur, at least at the considered time points. 
Since ex vivo cultured SVs exhibited a similarly 
elevated cellular apoptosis (Figure 2A-B), we investi-
gated whether application of a coronary-like flow 
pattern affected the phenotype of the surviving cells. 
To this aim, we performed IF staining with antibodies 
recognizing SMCs contractile markers αSMA (Figure 
3A)/Calponin (Figure 3B), and the synthetic SMCs 
marker Vimentin (Figure 3C). Cells quantification 
(Figure 3D) demonstrated a clear reduction in the 
percentage of αSMA+ and Calp+ cells in SV conduits 
stimulated with coronary flow/ pressure pattern, and 
a consistent increase in cells with synthetic character-
istics, suggesting a SMCs phenotypic transition.  
Coronary mechanics induces recruitment and 
proliferation of CD44+ cells in SV medial layer 
Recruitment of cells from the vascular adventitia 
has been identified as a key early event in VGD 
setting in animal vein arterialization models [24]. 
Furthermore, microscopic observations performed in 
explanted CABGs or SV grafts exposed ex vivo to 
trans-wall hypoxia gradients showed an enhanced 
growth of adventitia vessels [25]. Since CD44 marker 
expression has been associated to myofibroblast 
programming of stromal cells in fibrotic diseases [26, 
27], we investigated the expression of this marker 
after culturing SV grafts. In order to assess if cells 
expressing CD44 also expressed SMCs markers, we 
performed co-staining with anti-αSMA and -SM22α 
specific antibodies in control and ex vivo cultured SVs. 
As shown in Figure 4A-B very few CD44+ cells were 
present in the media of the vessels before the 
beginning of the culture. However, these cells 
increased time-dependently, in particular in CABG 
samples, where they exhibited a clear co-staining with 
SM22a. Quantification of cells confirmed that CD44+ 
and SM22α+ cell percentages increased under either 
VP or CABG stimulation at day 7, and continued to 
rise in CABG-stimulated vessels at day 14 (Figure 4C). 
The presence of CD44+/SM22α+ cells in CABG-treated 
SVs exhibited, finally, a substantial and constant 
increase (Figure 4C). Since the majority of CD44+ and 
SM22α+ cells at the beginning of the culture were 
confined in the adventitia in close association with the 
vasa vasorum (Figure S3), this suggests that coronary 
flow/pressure pattern activates adventitial cells 
expressing myofibroblasts/immature SMCs markers. 
In keeping with this conclusion, increase in 
CD44+/SM22α+ cells in CABG-stimulated grafts was 
associated to an elevated proliferation level (Figure 
5A-C), which was more pronounced initially in the 
adventitia (in particular in the vasa vasorum region), 
and later in the media, as detected by expression of 
PCNA marker. 
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Figure 1. (A) Low and high magnifications (zones enclosed in the yellow areas) of transversal sections of native SVs (T0) and SVs exposed to venous perfusion (VP) or coronary 
flow (CABG) for 7 and 14 days, stained with Masson’s trichrome. While in VP samples, the circumferentially arranged SMCs bundles (characterized by the red staining, yellow 
arrows) are present throughout the culturing period, in SVs exposed to CABG mechanics, part of these bundles disappeared (areas stained in blue, asterisks) leaving zones rich 
in collagen and deprived of cells. This suggests that circumferential SMCs bundles are a specific target of coronary flow mechanics. (B) Quantification of media thickness, 
confirmed a major effect of the CABG stimulation on SV wall remodeling. * indicate P < 0.05 by one-way ANOVA with Newman-Keuls post-hoc. Bar graphs represent mean and 
SE. Me = Media; Adv = Adventitia: In = Intima. 
 
Thrombospondin-1 is a mechanically regulated 
factor in the SV wall associated to SMCs 
switching from contractile to synthetic 
phenotype 
Mechanical forces exerted by the counter-pulsed 
coronary flow on vein wall expose vein-resident cells 
to a high level of strain, whose distribution is modi-
fied compared to the natural venous perfusion [12]. 
We then modelled in silico the level of cell 
deformation associated to the circumferential strain of 
the two major SV layers occurring in the presence of 
coronary flow mechanics. We were interested in this 
strain component considering the orientation of the 
circumferentially arranged SMCs bundles, which 
appeared the most affected structures in the media of 
CABG-stimulated SV conduits (Figures 1 and 3). As 
shown in Figure 6A, the model predicted a more 
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pronounced strain in the stiffer media (~ 26% 
elongation), and a lower strain value (~ 18% elonga-
tion) in the softer adventitia. Based on this evaluation, 
we decided to investigate the effects of uniaxial cell 
deformation on SMCs isolated from human SVs 
(Figure S4) using an in vitro cyclic cell strain setting. 
Figures S5 and 6B show the results of 24 and 72 h 
SMCs mechanical stimulation, which determined a 
significant reorientation of the cells. Under these 
conditions, these cells downregulated the contractile 
phenotype marker αSMA, and upregulated the levels 
of Vimentin (Figure 6B). They also exhibited a sub-
stantial rearrangement of the contractile cytoskeleton 
organization, which acquired an arrangement consis-
tent with the synthetic phenotype [21] (Figure S6). 
 
 
Figure 2. (A) Low and high magnifications (zones enclosed in the yellow areas) of transversal sections of native SVs (T0) and SVs exposed to venous perfusion (VP) or coronary 
flow (CABG) for 7 and 14 days stained with TUNEL assay for detection of apoptotic cells. Yellow arrows indicate TUNEL- cells while red arrows indicate TUNEL+ apoptotic cells. 
(B) Apoptosis quantification in the SV media at the two time points. * indicate P < 0.05 by one-way ANOVA with Newman-Keuls post-hoc. Bar graphs represent mean and SE. 
Me = Media. 
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Figure 3. (A-C) Confocal microscopy images of transversal sections of native SVs (T0) and SVs exposed to venous perfusion (VP) or coronary flow (CABG) for 7 and 14 days 
stained with antibodies recognizing contractile (αSMA, Calponin) and secretory (Vimentin) SMCs markers. Red arrows indicate cells expressing the indicated markers, while the 
cells indicated by white arrows are marker- cells. (D) Quantification of the marker+ cells expressed as a percentage of the total nuclei count present in the SV medial layer. Data 
are presented per treatment groups with blue bars indicating VP and red bars indicating CABG. * indicate P < 0.05 by one-way ANOVA with Newman-Keuls post-hoc 
comparison. Bar graphs represent mean and SE. 
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Figure 4. (A-B) Low and high magnifications of confocal images of SV tissue sections stained with CD44 with αSMA, (A) or SM22α (B) antibodies. While expression of αSMA 
was independent of that of CD44 (white arrows) a staining overlapping of CD44+ and SM22α+ (orange arrows) was observed especially in CABG samples at day 14 of stimulation. 
(C) Quantification of single marker+ cells or SM22α+/CD44+ cells in the medial layer of SV conduits exposed to venous perfusion or coronary flow revealed a sharp increase in 
double positive cells in the CABG conditions. * indicate P < 0.05 by one-way ANOVA with Newman-Keuls comparison tests; # indicate P < 0.05 by unpaired Student’s tests at 
the corresponding time points between the two treatments. Bar graphs represent mean and SE. 
 
In order to find a relationship between the 
phenotypic switch occurring in SMCs and the 
observed activation and presence of CD44+ cells, we 
performed a secretome analysis of proteins released in 
the culture medium by mechanically strained SMCs 
using a mass spectrometry-based approach. This 
indicated the matricellular protein Thrombospondin- 
1 (TSP-1) [28] as a factor released at high levels both at 
24 and 72 h of mechanical stimulation (Table S2). 
Mass-spec data were validated in independent 
biological replicates using IF and ELISA tests, which 
confirmed TSP-1 release from SMCs (Figure 6C). 
Interestingly, Western analysis of the protein extracts 
revealed a decrease of the intracellular content of 
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TSP-1 in mechanically stimulated SMCs (Figure 6C). 
Altogether these data indicate that mechanical strain 
induces release of TSP-1 from intracellular stores and 
a concomitant upregulation at transcriptional level, 
thus identifying TSP-1 as mechano-responsive gene. 
Finally, we performed immunohistochemistry and 
Western blotting analyses on tissue sections and 
protein extracts of samples treated with VP or CABG 
flow. This clearly showed a specific elevation of TSP-1 
in the intima and media compartments of 
CABG-stimulated vs. VP and control SVs (Figure 
6D-E). Immunofluorescence staining with anti-TSP-1 
and -SM22α antibodies indicated the presence of 
TSP-1+ cells with or without co-expression of the early 
SMCs marker in CABG-treated samples (Figure S8). 
 
 
Figure 5. (A-B) Immunofluorescence staining of CABG-treated SV conduits sections with PCNA marker in conjunction with CD44 (A) or SM22α (B). PCNA+ cells 
co-expressing (yellow arrows) or not co-expressing (rose arrows) the mesenchymal and the SMC markers were localized in the adventitia (Adv) at 7 days also in association with 
the vasa vasorum (VV) Dotted lines indicate the position of the external elastic lamina. (C) Quantification of CD44+/PCNA+ and SM22α+/PCNA+ cells in the medial layer. * indicate 
P < 0.05 by one-way ANOVA with Dunnett’s post hoc comparison test. Bar graphs represent mean and SE of observations. 
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Figure 6. (A) On the left side of the panel, a schematic of the structural components, the stiffness characteristics (expressed as Young’s modulus, E [kPa]) and the circumferential 
wall strain (εW) employed to compute cell stretching experienced by cells in the adventitial and in the medial layer when coronary blood pressure is applied. On the right side of 
the panel it is represented the predicted cell deformation maps in the medial (εW_Mcell) and adventitial (εW_AdvCell) layers, as a result of the circumferential wall strain. (B) Results 
of 10% cyclic stretching on orientation of SV-SMCs (see scheme showing the procedure adopted to calculate cellular orientation above the bar graph on the left); modulation of 
αSMA and Vimentin by Western blot analysis (right). (C) Western blotting and IF (left side and right side, respectively) of TSP-1 into mechanically stimulated cells; ELISA tests of 
TSP-1 release in the medium. TSP-1 gene expression analysis by Q-RT-PCR (central part of the panel). (D) TSP-1 immunohistochemistry in VP and CABG-stimulated SV samples. 
Statistical analysis indicated a significant difference in signal intensity at day 14 in CABG (red bars) vs. VP (blue bars) and T0 (white bars) samples. (E) Western blotting analysis of 
whole protein extracts from SV samples. As shown in the quantification graph, CABG-treated samples at day 14 (red bars) underwent a dramatic upregulation of TSP-1 compared 
with VP samples (blue bars) and earlier CABG time points, or controls. * indicate P < 0.05 by, (B, C) paired t-test, (D) one-way ANOVA with Newman-Keuls multiple comparison 
post-hoc test and unpaired t-test (E). Bar graphs represent mean and SE of observations. 
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Figure 7. (A) SVPs transwell migration assay; micrographs show the cells that migrated through the membrane pores stained with Crystal Violet (purple color). Bar graph 
indicates quantification of the Crystal Violet optical density (see methods). * indicate P < 0.05 by one-way ANOVA (repeated measures) with Newman-Keuls multiple comparison 
post hoc test. (B) FACS analysis of the main TSP-1 receptors in human SVPs (n = 4). (C-D) Inhibition of SVPs migration against recombinant TSP-1 (C) and strained SMCs 
conditioned medium (D) by CD47 blocking antibody. * in both panels indicate P < 0.05 by paired student’s t-test. (E) Effect of TSP-1/TGF-β treatment on SVPs phenotype. 
Q-RT-PCR analysis of TAGLN (SM22α), TGFβR, Col1A genes expression (upper). Data are represented as fold change (FC = 2-ΔΔCT) vs. untreated cells cultured for the same 
amount of time (dotted line). * indicate P < 0.05 by paired t-test performed on ΔCT values. Western blotting analysis of SM22α protein expression (lower). * indicates P < 0.05 
by paired t-test. (F) Effect of TSP-1/TGF-β treatment on SVPs proliferation (PCNA immunofluorescence, green). * indicate P < 0.05 by paired t-test. Bar graphs represent mean 
and SE of observations. 
 
TSP-1 induces migration of SV adventitial 
progenitor cells 
The human SV adventitia contains progenitor 
cells with pericyte characteristics, the so-called 
saphenous vein progenitors (SVPs) [20]. These cells 
are characterized by CD44 as well as other fibroblast/ 
stromal cells markers (Figure S9) [26], and may 
represent a potential source of cells participating to 
SV graft pathologic evolution by differentiating into 
myofibroblasts and SMCs [12]. In order to correlate 
the mechanical-dependent TSP-1 regulation in the SV 
wall and activation/recruitment of CD44+ cells, we 
performed migration assays in Transwells (Figure 
7A). Results showed that TSP-1 elevated the 
migration of the cells compared to serum only. As 
established in literature, TSP-1 exerts its cellular 
functions through specific receptors [28]. We therefore 
investigated the expression of TSP-1 receptors in SVPs 
using specific antibodies for CD36 and CD47, and this 
highlighted a high CD47 expression level (Figure 7B). 
To substantiate the role of TSP-1 on SVP migration, 
we treated cells with a blocking CD47 antibody in 
migration assays against the protein (Figure 7C) or the 
stretched SMCs conditioned medium (Figure 7D); in 
both cases, treatment with the antibody inhibited 
SVPs migration.  
Integration of mechanosensing- and 
humoral-driven pathways in pleiotropic SVPs 
responses in saphenous vein graft failure 
Taken together, the previous data suggested that 
CD44+/SM22α+ cells growing in SV conduits exposed 
to coronary mechanics are actively recruited from the 
adventitia where they initially reside; conversion from 
contractile to synthetic SMCs due to circumferential 
strain component attracts these cells in the medial 
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layer through secretion of TSP-1 and CD47-mediated 
chemotaxis. To get further insights in this process, we 
reasoned that transitioning from the adventitia to the 
media could expose cells to a combination of stimuli 
resulting from TSP-1 and classical vascular pro- 
remodeling factors, such as TGF-β [29]. On the other 
hand, we already showed that arterial-mimicking 
pressure elevates the expression of TGF-β in the SV, 
and literature reported a crucial function of TSP-1 for 
TGF-β pathologic activation of cells with mesen-
chymal and smooth muscle cells phenotypes [30, 31]. 
In order to substantiate this hypothesis, we stimulated 
SVPs with TGF-β (10 ng/mL) and TSP-1 (50 ng/mL), 
alone or in combination, followed by analysis of 
SM22α, Collagen1, TGF-βR, and cell proliferation. 
Results showed an increase in the expression level of 
the SMC/myofibroblast differentiation markers 
(Figure 7E-S10) and proliferation (Figure 7F-S11) at 
both times in cells treated with the factors combina-
tions. For a final confirmation of TSP-1 expression in 
failing of arterialized veins, we performed immuno-
staining with TSP-1 antibodies in sections of SV grafts 
transplanted into carotids in pigs [32]. As shown in 
Figure 8A-C, SV grafts underwent a significant 
thickening of the intima layer, which peaked at 90 
days post-transplantation. Concurrently, an increased 
number of cells expressing TSP-1(Figure 8B-C) and of 
SM22α+/CD44+ cells (Figure 8D) was observed in the 
wall of the implanted SVs. 
Discussion 
We and others have hypothesized an important 
role of hemodynamic forces in molecular 
programming of the SV graft disease [12]. On the 
other hand, the lack of platforms mimicking the 
peculiar flow/pressure pattern existing in the 
coronary circulation has prevented the identification 
of molecular pathways connected to alterations of SV 
mechanics directly in human samples. In the present 
investigation we filled this gap using a platform 
customized to maintain vessel viability and 
reproducing the hemodynamic conditions of the 
coronary circulation [18]. We found a major vessel 
remodeling effect consisting in, i) a substantial 
rearrangement of the intima and the media layers 
structure, ii) a major change in cell composition 
resulting from an early induction of apoptotic death 
in a significant portion of the SMCs, accompanied by 
a transition from a contractile to a synthetic 
phenotype of the surviving SMCs associated with 
TSP-1 release in the media, and iii) proliferation of a 
vessel-resident cell subset arising from the SV 
adventitia, characterized by expression of CD44 and 
SM22α, leading to a fibrotic-like response associated 
to TSP-1 release. 
Coronary mechanics induce SMCs phenotypic 
transition toward a synthetic phenotype and 
growth of a myofibroblast-like cell population 
in the SV media 
The first questions that we aimed to resolve was 
to define the structural rearrangement of the vessel 
wall subjected to CABG conditions and the cellular 
dynamics occurring in consequence of the coronary 
stimulation vs. the venous flow/pressure pattern. 
As shown in Figures 1, S1 and S2, under CABG 
conditions, the SV wall underwent a consistent thin-
ning with reduction of the overall media thickness. 
Interestingly, the coronary-like stimulation was not 
associated to intima growth, while VP-stimulated 
vessels (analogous to the conventionally accepted SV 
culture method) exhibited significant intima thicken-
ing at day 14. This result, although contra-intuitive, is 
in line with observations performed in SV CABGs 
explanted post mortem showing narrowing of the vein 
wall and absence of intima hyperplasia at early times 
after implantation [33]. It further supports the 
hypothesis, already made in two other previous 
publications from our groups [18, 25], that the SVs 
contain a certain degree of damage before the culture 
that depends on surgical manipulation (e.g. 
interruption of collateral vessels, partial removal of 
the adventitia). In support of this hypothesis is, 
finally, the finding that TUNEL staining showed a 
similar level of apoptotic cells, especially at 7 days of 
culture, irrespective of the flow pattern (Figure 2). 
IF data indicated that coronary mechanics 
induced synthetic SMCs phenotype, with a decrease 
in αSMA and Calponin and a parallel increase in 
Vimentin in the media layer (Figure 3). This is 
consistent with observations performed in animal 
models, in which medial SMCs lose contractile 
markers in favor of a synthetic phenotype [34, 35]. It is 
interesting to note that while disappearance of cells 
with contractile markers peaked at day 7, a consistent 
increase in Vimentin+ cells occurred at day 14 of 
CABG stimulation. Thus, the shift in SMCs phenotype 
in the media was likely an effect of the adaptation of 
the cells surviving the early apoptotic peak to the new 
mechanical conditions. This conclusion is in line with 
reported differences in biological responses of 
synthetic SMCs to mechanical strain compared to 
their contractile counterparts [36]. The different 
response of these cells in the CABG mechanical 
condition may be finally part of the TSP-1-mediated 
pathway, given the reported protective effects from 
apoptosis of TSP-1/CD47 interactions in SMCs [37]. 
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Figure 8. (A) Low and high magnifications (zones enclosed in the yellow areas) of transversal sections of porcine SV grafts before, and after 14 and 90 days in vivo arterialization. 
Yellow arrows indicate the intima basal lamina (BL). (B) Low and high magnifications (zones enclosed in the yellow areas) of section stained with anti TSP-1 antibody. Yellow 
arrows indicate TSP-1+ cells. (C) Quantification of intima thickening and of TSP-1+ cells. (D) Staining with antibodies directed against SM22α and CD44 of control (T0) and in vivo 
arterialized (day 14; day 90) SV in pigs. In the high magnifications on the bottom (correspondent to the zones enclosed in the yellow areas), orange arrows indicate cells 
expressing the two markers. * indicate P < 0.05 by one-way ANOVA with Newman-Keuls post-hoc test. Bar graphs represent mean and SE of observations. 
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Our immunofluorescence analyses of the SV wall 
revealed that in CABG condition, the vascular wall 
was repopulated by cells expressing the mesenchymal 
marker CD44 and early SMC marker SM22α. Due to 
marker overlapping between these strictly associated 
cell types, and the absence of methods to perform 
lineage-restricted cell tracking in the human tissue, it 
is at present not possible to conclude definitively 
whether these cells derive from direct activation of 
pre-existing CD44+/SM22α+ SMCs or of progenitors 
with pericyte characteristics associated to vasa 
vasorum[38]. CD44 is, in fact, the ligand for 
hyaluronan, and it is involved in cell-cell/cell-matrix 
interactions in SMCs, myofibroblasts and inflamma-
tory cells. This glycoprotein has been associated with 
SMCs differentiation [39], and high levels of CD44 
have been associated with cell migration, injury- 
induced remodeling and fibrosis [27, 40]. SM22α/ 
Transgelin is a F-Actin associated protein expressed in 
smooth muscle cells and fibroblasts, whose control 
has been recently associated to cell mechano- 
transduction [41]. Interestingly, in unstimulated 
samples SM22α+/CD44+ cells were found almost 
uniquely in the adventitia in the vasa vasorum region, 
from where they appeared to invade the media at the 
later time point, especially in CABG condition (Figure 
S3, Figure 5). This finding is suggestive of a two-step 
adventitial cells recruitment process consisting of, at 
first, activation in the adventitia and, thereafter, active 
migration/proliferation in the media. Although these 
results are in contrast with findings obtained by 
passive culturing of SV vein rings (where there is no 
intervention of mechanical forces, Figure S1-S2) [23], 
they confirm findings in real CABGs explanted post 
mortem, where no intima hyperplasia was observed 
up to one month after implantation [33] and previous 
results obtained in our laboratory showing a 
structural rearrangement of vasa vasorum in response 
to hypoxia or mechanical injuries [19, 25]. 
Furthermore, they are in line with studies showing 
the contribution of adventitial progenitors to vein 
graft failure in animal models of vein arterialization 
[24]. 
A matricellular pathway mediated by 
Thrombospondin-1 accounts for activation of 
resident myofibroblast-like cells in SVs 
exposed to coronary mechanics 
Cell sensitivity to mechanical cues is becoming 
more and more relevant for the progression of chronic 
fibrotic diseases as a fundamental part of damage 
repair process [42, 43]. Our in silico modelling of the 
cell strain in the two main layers of the SV wall 
predicted a particularly elevated level of mechanical 
stress for SMCs in the media (particularly those 
arranged in the circumferentially arranged bundles) 
(Figure 6). It was therefore crucial to expose these cells 
directly to cyclic mechanical stress in vitro and assess 
existence of signals secreted by these cells potentially 
involved in activation of adventitial resident cells. 
Given that in vivo mechanical stress sensed by these 
cells has a major uniaxial component [12], we 
performed a stimulation protocol along a unique 
direction with a 10% deformation level. Although this 
protocol led cells to experience a nominal deformation 
level lower than the maximal predicted by the model 
in the SV wall, we reasoned that mechanical forces in 
the real tissues is sensed by cells with a complex 
dynamics involving partial absorption by 
surrounding matrix due to its viscoelastic properties, 
while in the 2D condition cellular deformation occurs 
through direct transmission of elastic forces to 
cytoskeleton by the focal adhesion complexes [44]. 
The choice of a mass spectrometry approach to 
analyse the secretome of strained SMCs was made to 
not restrict our search for possible paracrine factors 
only on growth factors and chemokines that have 
been classically involved in progression of VGD, but 
also on the potential role of secreted proteins such as 
ECM components or matrix remodeling enzymes [29]. 
On the other hand, recent investigations by global 
proteomic profiling have disclosed new roles for 
ECM/matricellular vascular composition changes in 
early remodeling responses after injury [45]. Our 
secretomic analysis revealed TSP-1 as the factor more 
robustly released in the conditioned medium by 
SMCs subjected to mechanical stress. The role of 
TSP-1, and in a more general view, of members of the 
Thrombospondin family, have been so far connected 
to various effects on SMCs and vascular cells, such as 
focal adhesion kinase function, ERK1/2, p38 and 
CD44 regulation, migration, proliferation and arterial 
remodelling [46], but never specifically linked to 
VGD. This is important, especially in the view of 
recent evidences showing the susceptibility of TSP-1 
expression/function to mechanosensitive control in 
formation of aortic aneurysm [47] or in disturbed 
flow-dependent arterial stiffening [48]. Although the 
objective of the present study was not to establish 
links between the response to mechanical cues and 
TSP-1 secretion by SV-SMCs, or to unveil the identity 
of mechanotransduction-dependent machineries 
controlling TSP-1 gene expression at transcriptional 
level, it was remarkable to observe a sustained release 
of this factor specifically in the medial layer of 
CABG-stimulated human vessels (Figure 6, Figure 
S8), or in in vivo arterialized SV grafts (Figure 8). 
Together, these evidences support the hypothesis that 
release of TSP-1 in the vascular wall by SMCs is a 
damage response caused by SMCs mechanical stress 
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linked to the altered vessel flow dynamics, and 
potentially activating/recruiting adventitial cells with 
a myofibroblast phenotype. 
Inspired by the vision of a mechano-paracrine 
mechanism involving TSP-1 in SV remodeling 
process, we finally established a mechanism for 
activation of adventitial cells in SV graft pathophysio-
logic process. Even if these cells have been extensively 
characterized for their vascular regeneration potential 
[20], the expression of several markers in common 
with mesenchymal cells such as CD105, CD90 and 
CD44 (Figure S9) suggests a specific vascular patho-
physiologic role [38]. In our cell migration setting we 
observed a chemotactic effect of TSP-1 on SVPs. This 
effect was specific and involved CD47, one of the 
common TSP-1 receptor, expressed at high levels in 
these cells (Figure 7). Furthermore, compared to the 
treatment with the single factors, the combined 
treatment with TSP-1 and TGF-β increased SVPs 
maturation toward a SMC/myofibroblast phenotype, 
as shown by results of TAGLN1, TGFBR1 and Col1A 
genes expression, SM22 protein expression and 
proliferation (Figure 7, Figure S10-S11). Taken 
together, these results support a multiple role of TSP-1 
in activating myofibroblast-like progenitors migration 
from adventitial vasa vasorum and in modulating the 
latent TGF-β signaling, to promote maturation and 
proliferation of these cells in the media [49]. This 
hypothesis is in line with previous observations 
performed in mesenchymal progenitors [30] and 
SMCs [46], and establishes a new function of TSP-1 in 
early mechanical-dependent modification of matri-
cellular composition in human SV grafts. The 
potential of our mechano-dependent graft pathology 
model was finally tested in the SV into carotid 
interposition in pigs, a widely accepted, robust and 
reproducible large animal system to assess vein 
arterialization. Data obtained in this system (Figure 8) 
confirmed the overexpression of TSP-1 and in the 
vascular wall of transplanted SVs and a similar 
dynamics of SM22α/CD44+ in the adventitial region, 
and this correlated with neointima accumulation. 
In conclusion, our study unravels for the first 
time a molecular mechanism linking mechanical 
injury occurring in coronary SV grafts with 
programming of intima hyperplasia by a mechano- 
paracrine effect. While this evidence demonstrates the 
relevance of cell-based mechanosensing in fibrotic 
diseases of the cardiovascular system, it calls for more 
focused studies addressing the potential reduction of 
intima thickening, e.g. by treatments with peptides 
inhibiting the TSP-1 function to resolve the timely 
issue of venous CABGs occlusion [50]. 
Supplementary Material  
Supplementary methods, figures, and tables. 
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Supplementary Methods 
Ex vivo SV tissue stimulation  
For bioreactor-based ex vivo stimulations, we employed exclusively SV segments obtained from patients 
undergoing CABG intervention (Table S1). To minimize the damage due to vessel manipulation in the surgery 
theatre, SVs employed for CABG implantation were harvested using a ‘no touch’ procedure[1, 2], which 
maintains almost integrally the adventitia. This is a standard procedure adopted by our cardiac surgery Teams 
to maintain patency in implanted SV grafts and maximize the clinical outcome. In order to maximize the 
vitality of the SV, the vessels were maintained hydrated in saline solution for the whole duration of the surgery. 
After vessels were released from the surgery room, they were stored in DMEM supplemented with 10% FBS, 
1% L-Glutamine (L-Glut), 1% P/S (all by Lonza) at 4 °C until ex vivo tissue stimulation into bioreactors. As a 
quality checking process, they were measured in length and calibre at the two extremities. Indeed a variable 
calibre and length of the vessels may result into significant variability in the flow/pressure patterns experienced 
especially in the CABG. In any instance, SVs shorter than 5 cm and with a calibre < 5 mm were excluded from 
the study. Additionally, to avoid confounding boundary effects, the parts of the SVs considered to analyse the 
effect of mechanical forces were derived from the central portions (~3 cm in length) while the two extremities 
that were anchored to inlet/outlet of the stimulation systems by vessel loops were always discarded. SV 
segments were mounted in an EVCS mimicking coronary hemodynamics (CABG-like stimulation, luminal 
pressure: 80 - 120 mmHg; pulse frequency: 1 Hz; mean flow rate: ~150 mL/min)[3] or venous conditions as 
controls (VP, continuous luminal pressure: 5 mmHg; flow rate: 5 mL/min)[4, 5] and cultured for 7 or 14 days. 
DMEM supplemented with 10% FBS, 1% L-Glut, 1% P/S, and containing 3.5% Dextran (450000-650000 
kDa, Sigma-Aldrich) was used to mimic blood-like viscosity of 3.2 cP in CABG-like stimulation. Medium 
(1/2 of the volume) was changed every 4 days. At the end of the stimulation period, SV samples were 
recovered. Portions of the stimulated SV were in part processed for histology and immunofluorescence and in 
part for proteomic analyses. Untreated tissue rings of each SV sample were fixed and snap-frozen upon arrival 
from the surgery theatre and stored to serve as baseline controls. In addition, to validate our venous control 
condition, we determined intima thickness after conventional passive culture of SV segments, a common 
model of intimal hyperplasia described before[6-8], in which rings are cultured in medium (DMEM 
supplemented with 10% FBS, 1% L-Glut, 1% P/S) in the absence of mechanical stimuli. 
Tissue morphometry and immunohistochemistry 
Fixed tissue rings were embedded in paraffin and cut at 5 µm using a rotary microtome (Leica). Lumen 
perimeter and the distance of the outer part of the media were measured on sections stained with Masson’s 
trichrome (MT) staining. Intima thickness was measured on sections stained with Weigert van Gieson (WvG, 
both from Bio-Optica Milano, Italy), and media thickness was determined as the difference between the two 
measurements. Digital images were acquired using a light microscope and dedicated software (AxioVision 
Bio Software, Carl Zeiss, Germany). For immunohistochemistry, after heat-induced epitope unmasking (citrate 
buffer, pH 6, 10 min) and quenching with hydrogen peroxide (0.6%, 20 min), nonspecific binding was blocked 
with bovine serum albumin (BSA 3%, 45 minutes, Sigma-Aldrich) and sections were incubated overnight with 
a primary antibody against TSP-1 (mouse anti-human A6.1, 2 μg/mL, Invitrogen). Subsequently, sections were 
incubated with a secondary antibody (rabbit anti-mouse IgG HRP, Invitrogen) for 1 h, after which colour was 
developed with diaminobenzidine (ImmPACT DAB, DBA, Italy) and nuclei were counterstained with 
hematoxylin. Apoptosis was determined on sections stained with the Deadend Colorimetric TUNEL System 
(Promega, Italy) according to the manufacturer’s protocol and with a hematoxylin counterstain. 
Tissue and Cell Immunofluorescence  
Immunofluorescence (IF) staining for different markers was performed on sections after epitope unmasking 
and blocking with BSA (3%, 1 h). Sections were incubated overnight at 4 ˚C with primary antibodies and 
subsequently with appropriate AlexaFluor-conjugated secondary antibodies (Invitrogen) for 1 h at RT (Table 
S3). Cells positive for the different markers, counted in at least 3 fields per section, were expressed as 
percentage of total cells in the media. For cellular IF, after fixation with 4% paraformaldehyde (Sigma-
Aldrich), cells were permeabilized for 30 min at RT with PBS containing 3% (w/v) BSA and 0.2% (v/v) Triton 
X-100 (AppliChem), followed by primary antibody incubation at 4 °C overnight. Negative control cells were 
incubated in a PBS solution containing 3% BSA. AlexaFluor labelled secondary antibodies were employed to 
detect primary antibodies. Digital images were obtained using an ApoTome fluorescence microscope or LSM-
710 confocal scanning microscope (both Carl Zeiss, Germany). All measurements and quantifications were 
performed using ImageJ (version 1.46r, National Institutes of Health, USA). Analysis of 3 fields per section 
was found to be a good representation of markers expression in the whole tissue, based on the magnification 
used (10 X), and the average size of the sections. Four sections representative of four consecutive portions of 
the stimulated vessels were quantified for each condition and for each marker. Positive cells were counted in 
image files blinding the type of stimulation to the examiner. Marker+ cells were generally scored just when 
they clearly exhibited a complete staining around (membrane markers) or inside cytoplasm (cytoskeleton) or 
nuclei (proliferation markers). This staining pattern was visible only in tissue sections stained with the 
primary/secondary antibody combinations and not in control staining that were included in every set of 
immunofluorescence labelling. 
Isolation and culture of SV-derived cells 
SVPs and SMCs for in vitro experiments were isolated from SVs of patients subjected to unilateral 
saphenectomy (Table S1). SVP isolation was performed as described previously [9]. In brief, the vein was 
mechanically minced and digested for 4 h at 37 °C with 3.7 mg/mL Liberase 2 (Roche). Remaining aggregates 
were removed through filtration with 70 μm and 40 μm cell strainer. CD34POS/CD31NEG cells were isolated by 
magnetic bead-assisted cell sorting (MACS, Miltenyi Biotec). Cells were grown in a humidified atmosphere 
(95% air, 5% CO2) at 37 °C in Endothelial Growth medium (EGM-2) supplemented with 2% Fetal Bovine 
Serum (FBS) and 1% Penicillin/Streptomycin (P/S, all by Lonza). For SMCs isolation, after removing the 
external tissues, including the adventitia, veins were cut longitudinally to remove the endothelium by gentle 
scraping and then finally minced. Tissue fragments were incubated in Dulbecco Modified Eagle’s Medium 
(DMEM) containing Liberase for enzymatic digestion. The resulting cells were cultured in DMEM 
supplemented with 10% FBS and 1% P/S. Passages between 4 and 6 were used for the experiments. 
SVPs flow cytometry characterization 
SV-derived progenitor cells were characterized by flow cytometry analysis. Cell suspensions were incubated 
with a combination of directly conjugated antibodies against CD31, CD36, CD44, CD47, CD90, CD105, 
CD140b and NG2 (all from BD Bioscience) for 15 minutes at room temperature (RT) in the dark. Data were 
acquired with FACSAria flow cytometry (BD Biosciences) and analyzed with flow cytometric sorting Diva 
software (BD Biosciences). 
In silico modelling of strain responses in SV media and adventitia 
An in-silico model was implemented with the aim of quantifying the deformation experienced by the cells 
embedded in different extracellular matrices, namely the adventitial layer or the medial layer. The cell was 
assumed as a 10 µm-diameter sphere embedded in an ECM volume. The cell and the ECM perfectly adhere at 
their interface. A 40 µm-edge cubic ECM volume was modelled around the cell, with two additional lateral 
extension volumes that were used to smooth the edge effects caused by the application of lateral displacements 
as the mechanical loading condition. The overall volume (ECM plus cell) was meshed with about ~ 230.000 
tetrahedral elements. A linear elastic constitutive model was used for the materials representing the ECM and 
the cell. Young’s moduli were set according to the literature:  Young’s moduli were set according to literature: 
1 kPa for cells [10] 2 kPa for the adventitia (which was treated as a soft collagen matrix [11]) and 88 kPa for 
the media layer [12, 13]. Lateral displacements were applied to the lateral surfaces of the extension volumes, 
in such a way as to simulate a 16% strain for the cubic ECM volume. Such strain value was meant to represent 
the circumferential strain at which the vessel matrix is subjected when it is loaded with an arterial-like pressure. 
It was estimated by means of the Laplace law, considering blood pressure in the range 80-120 mmHg, a vessel 
diameter of 2.5-3 mm, a media thickness of 0.52 mm (as measured from histological slices of 9 SV samples), 
and the media Young modulus of 88 kPa, under the assumption that the pressure load is supported entirely by 
the medial layer. 
In vitro cell straining 
To investigate the effect of isolated mechanical strain on cultured cells, SMCs were subjected to cyclic strain 
using the FlexCell Tension Plus FX-5000T system (Flexcell International Corp., Hillsborough, NC). Before 
cell seeding, six-well Uniflex plates were surface-coated with bovine fibronectin (10 μg/mL; Sigma- Aldrich) 
in PBS after covalent crosslinking with a crosslinking reagent (sulfosuccinimidyl 6-(4'-azido-2'-
nitrophenylamino) hexanoate; Sulfo-SANPAH; Pierce) at 0.2 mg/mL in Hepes 50 mM (pH 8.5), photo-
activated by exposure to UV-light (365 nm). Cells were seeded 105/well and allowed to attach overnight before 
beginning the uniaxial cyclic deformation protocol (0-10% deformation, 1 Hz frequency), for 24 and 72 h. 
Static controls were provided by seeding an equal amount of cells into the same FN-coated plates, keeping 
them under the same atmospheric conditions but without mechanical stimulation. 
Western and ELISA analyses 
Western blot analyses were performed according to standard procedures. Cells were lysed in a buffer 
containing 10 mM Tris-Cl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% (v/v) Triton X-100, 1% (w/v) sodium 
deoxycholate, 0.1% (w/v) sodium dodecyl sulfate and 1% (v/v) protease and phosphatase inhibitor mixture 
(Sigma-Aldrich). Whole cell lysates were sonicated, centrifuged for 15 min at 14 000 g; cell supernatants were 
then collected. Proteins were quantified by BCA protein assay kit (Pierce Chemical Co). Cell lysates (30 μg 
per lane) were diluted in Laemli sample buffer, heated at 95 °C for 5 min, run onto 4-12% gradient SDS-
polyacrylamide gels (Invitrogen), and transferred to nitrocellulose membranes. The blots were blocked with 
Tris Buffered-saline containing 5% (w/v) nonfat dried milk (AppliChem) at RT for 1 h. Overnight incubation 
at 4 °C with primary antibodies listed in Table S4 was performed to examine individual protein expression. 
Membranes were finally incubated with appropriate secondary antibodies for 20 min. Images were taken by 
LI-COR Odyssey and band densities were quantified using ImageJ software. An enzyme-linked 
immunosorbent assay (ELISA, #BMS2100, Invitrogen) was performed on conditioned medium of strained vs. 
control SMCs according to the manufacturer's instructions to detect the levels of human TSP-1. Calibration 
curves were prepared using purified standards for the protein assessed and curve fitting was accomplished by 
regression following the manufacturer's instructions. 
mRNA analysis  
Total RNA was extracted from cell lines using TRIzol (Invitrogen), quantified with NanoDrop-1000 
spectrophotometer (Thermo Fisher Scientific) before integrity assessment with an Agilent 2100 Bioanalyzer 
(Agilent Technologies). Superscript III (Thermo Fisher Scientific) was used for reverse transcription. 
Quantitative real-time PCR analysis were performed with Power SYBR Green PCR Master Mix (Applied 
Biosystems) in an ABI 7900 Fast thermal cycler to detect TSP-1, TAGLN, TGFβR, Coll1A gene amplification 
products (primers details in Table S5). The reported expression levels were calculated relative to GAPDH 
mRNA, used as an internal standard control. The fold change of the genes in strained condition vs. control 
samples was calculated as 2 -ΔΔCT and the statistical analysis was done on the ΔCT values. 
Mass spectrometry of culture supernatants 
For the analysis of cell secretome by label-free mass spectrometry, the conditioned media were collected from 
strained or not-strained SMCs and processed as described [14, 15]. Quantitative label-free LC-MSE was 
performed on a hybrid quadrupole-time of flight mass spectrometer (Synapt-MS, Waters Corporation, Milford, 
USA) as previously described [16, 17]. The proteins were identified and quantified using Progenesis QIP for 
proteomics (v3.0, NonLinear dynamics, Newcastle upon Tyne, UK) with a human species-specific UniProt 
database (release 2017.1; 20,201 entries). For SVPs migration with static/dynamically cultured SMCs 
conditioned medium, the culture supernatant of 3 SMCs independent donors was pooled after ELISA test 
checking of TSP-1 and concentrated by lyophilizing/dialyzing. TSP-1 content of the resuspended CM was 
checked by ELISA before performing migration experiments. 
 
SVP Migration assay 
Migration capacity was measured by Transwell assays (Corning). SVPs (15,000) were seeded in EGM-2 
without FBS in the upper part of a cell culture-chamber-insert system separated from the lower chamber by an 
8 μm PET membrane. In the lower compartment, four conditions were assayed: EGM-2 without FBS (negative 
control), EGM-2 plus 10% FBS (positive control), EGM-2 plus recombinant human TSP-1 (experimental 
condition 1, 10 μg/mL, R&D Systems) and EGM-2 10% FBS plus TSP-1 (experimental condition 2, 10 
μg/mL), or SMCs conditioned medium. After 24 h, non-migrating cells in the upper compartment were 
scrapped off with a cotton swab, while cells on the lower side of the membrane were fixed with 4% 
paraformaldehyde for 10 min and permeabilized with methanol for 20 min at RT. Migrated cells were then 
stained with 1% (w/v) Crystal Violet diluted in 2% (v/v) ethanol for 30 min and images were acquired with 
Axiovert 200M (Zeiss). For Crystal Violet quantification, the staining was solubilized with 2% (v/v) SDS and 
optical density (550 nm) was measured using Infinite M200 PRO reader (Tecan). To inhibit TSP-1-dependent 
migration, cells were incubated at 37 °C for 30 min in serum-free EGM2 in presence or absence of function 
blocking antibody to CD47 (clone B6H12, 20 μg/mL, Invitrogen) and its isotype control (IgG1, 20 μg/mL, 
Invitrogen) before subjecting them to the transwell assay. 
In vivo porcine arterialization SV model 
Anaesthesia was induced with intramuscular ketamine administration (0.1 mg/Kg). After endotracheal 
intubation, anaesthesia was maintained using halothane, the animals ventilating spontaneously throughout. A 
12-15 cm of the left long saphenous vein was isolated using a ‘no touch’ technique[18-21], the vein divided 
and stored in iso-osmotic sodium chloride solution (containing 2 IU/mL heparin (CP Pharmaceuticals Ltd, 
Wrexham, UK) and 50 µg/mL-glyeryl trinitrate (Schwarz Pharma, Bucks, UK; room temperature) until 
required, to prevent spasm. The animal was heparinized by intravenous administration of 100 IU/Kg of 
heparin. Both common carotid arteries were exposed via longitudinal neck incisions medial to the 
sternomastoid muscle. End-to-end interposition grafts were created in both common carotid arteries (using 
continuous 7-0 Prolene or Surgipro), with reversed 45°-bevelled 3 cm segments of saphenous vein replacing 
45°-bevelled 1 cm excised segments of carotid artery. The proximal and distal anastomoses were 
approximately 4 cm apart. The order of performing the grafts and the site of insertion (left or right) were 
randomized between procedures and the vein segments. Neck and leg wounds were closed in layers, and the 
animals given antibiotic cover (ampicillin (200 mg amfipen (MSD Animal Health, UK) in sterile water i.m.) 
and appropriate levels of analgesia (buprenorphine (Vetergesic (Ceva Animal Health Ltd, UK) 15 μg/Kg i.m.), 
repeated as necessary). Animals were observed continually during recovery, which always took less than 1 h. 
Once recovered, the animals were inspected daily and fed a normal diet and given water ad libitum. Analgesia 
was continued as required, but no animal required additional antibiotic cover. 
  
 
Figure S1. Low and high magnifications (zones enclosed in the yellow areas) of transversal sections of 
conventionally cultured SVs to show intima hyperplasia (IH) as demonstrated in the literature [22]. Yellow 
arrows indicate the basal lamina (BL), particularly evident in B/W pictures of Weigert van Gieson staining. 
Bar graph on the bottom shows quantitative evaluation of intima thickness at the indicated time points. * 
indicates P < 0.05 by one-way ANOVA with Newman-Keuls multiple comparison post-hoc test. Me = Media; 
In = Intima. Bar graph represent mean and SE of observations.  
 
  
  
Figure S2. Low and high magnifications (zones enclosed in the yellow areas) of transversal sections of native 
SVs (T0) and SVs exposed to venous perfusion (VP) or coronary flow (CABG) for 7 and 14 days stained with 
Weigert van Gieson solution. Yellow arrows indicate the basal lamina (BL) evident in high contrast B/W 
pictures. Bar graphs on the right show quantitative evaluation of intima thickness at the indicated time points. 
* indicates P < 0.05 by one-way ANOVA with Newman-Keuls multiple comparison post-hoc test. Me = 
Media; In = Intima. Bar graphs represent mean and SE of observations.  
 
  
 Figure S3. Low (A) and high (B) magnification of Control (T0) SV transversal sections stained with CD44 
and SM22α antibodies. Note the localization of CD44+ (white arrows) or CD44+/SM22α+ cells (orange arrows) 
in association with the vasa vasorum (VV). Dotted line indicates the position of the external elastic lamina 
between the adventitia (Adv) and the media (Me).  
 Figure S4. Characterization of SV-SMCs by immunofluorescence staining with anti PDGFR-b, αSMA, 
SM22α, Vimentin and Tropomyosin-4 (TPM4) specific antibodies.  
 
 
 Figure S5. The panel shows the results of 24 and 72 h mechanical stimulation with a 10% uniaxial stretching 
regimen in the FlexCell device. The pictures in the centre show the structure of the F-actin cytoskeleton (in 
red, stained with Phalloidin-TRITC) in control and mechanically trained cells. The drawing in the upper part 
of the panel show the criterion that was adopted to assess the mechanical responses of the cells to cyclic 
elongation as already described by us. Namely, the frequency of the angles (θ) comprised between the major 
axis of the cell nuclei and an ideal orthogonal direction to the stretching were calculated and represented. From 
the graphical representation [23], it is evident that mechanically stimulated cells acquired a preferentially 
orthogonal specific orientation of their nuclei (red bars) demonstrating cytoskeleton rearrangements and 
mechano-sensitivity.  
 Figure S6. Immunofluorescence staining with antibodies for contractile/secretory phenotype in SV-derived 
SMCs subjected to mechanical strain for 72 h. In panel A, a double staining with Phalloidin-TRITC (red) and 
αSMA antibody (green) is shown in control cells and cells subjected to strain. Panel B represents the 
distribution of the focal adhesion contacts, as detected with Vinculin antibody (green dots connected to the F-
actin cytoskeleton, red); arrows indicate cells with a lower organization of the F-Actin cytoskeleton and a 
reduced number of focal contacts. Panel C shows the expression and the intracellular distribution of Vimentin 
(green fluorescence). In keeping with previous data [24] and biochemical results shown in Figure 6B, the lower 
polymerization and organization of the αSMA+ fibres (A), the reduced number of focal contacts (B) and the 
higher presence of Vimentin (C), these staining confirm the phenotypical transition between the contractile 
(static) and the secretory (dynamic) phenotype of SV-SMCs.   
 Figure S7. The upper picture shows the region of interest (ROI) in the vessel (comprising the media and the 
intima layers) where TSP-1 was quantified (see also Figure 6D). The lower panels show the Image J-based 
system used to quantify the expression of TSP-1 in the tissue. In order to make possible statistical comparisons 
(Figure 6D), the area (TSP-1+ area) occupied by black pixels was quantified and expressed as a percentage of 
the total area.  
 
 
 Figure S8. Immunofluorescence staining with antibodies recognizing SM22α (green fluorescence) and TSP-
1 (red fluorescence) in SV samples before (T0) and after culture under venous (VP) or coronary (CABG) 
flow/pressure pattern for 14 days. It is evident that coronary flow mechanics increased expression of TSP-1 in 
cells expressing (yellow arrows) or not expressing (rose arrows) SM22α in the SV media. White arrows 
indicate SM22α+ in the picture showing the media of VP-treated SV sample.  
 Figure S9. Characterization of human SVPs. Cells were culture amplified as described in methodological 
section and in reference publications[9, 25], exploiting their CD34+/CD31- antigenic repertoire. As shown in 
the FACS histogram plots, SVPs expanded in culture expressed high levels of mesenchymal markers CD90, 
CD105 and CD44. NG2, a pericyte marker characterising cells in the SV vasa vasorum was, at least in part, 
downregulated. Bar graph represents average expression level and the relative SE of each marker in n = 37 
SVPs preparations.  
 
 
 
 
 Figure S10. Effect of TSP-1 and TGF-β treatment on variations of SM22α expression in SVPs exposed to 
single or combined treatment (See also Figure 7E). * indicate P < 0.05 by one-way ANOVA with Newman-
Keuls’s comparison test. Bar graph represents mean and SE. 
 
  
 
 
 
 Figure S11. Effect of single/combined TSP-1/TGF-β treatment on variations in SVPs proliferation (Figure 
7F). * indicate a statistically significant difference (P < 0.05) in the percentage of the PCNA+ cells in cells 
treated with TSP-1 + TGF-β vs. all the other treatments at both time points. # indicate a statistically significant 
difference (P < 0.05) in the percentage of the PCNA+ cells in TGF-β treatment vs. CTRL and TSP-1 treatment. 
Statistical analysis was performed by one-way ANOVA with Newman-Keuls multiple comparison post-hoc 
test. Bar graphs represent mean and SE of observations.  
  
 
Variable Saphenectomy patients 
(n = 66) 
CABG patients  
(n = 21) 
Age (y) 56 ± 13 68 ± 2 
Male, n (%) 35 (53%) 19 (90%) 
Hypertension, n (%) 16 (24.2%) 17 (94.4%) 
Dyslipidaemia, n (%) 8 (12.1%) 10 (62.5%) 
Diabetes, n (%) 3 (4.5%) 6 (35.3%) 
Body mass index 26.5 ± 4.3 26.9 ± 0.6 
Smoking, n (%) 22 (33.3%) 9 (42.9%) 
Glycaemia 102 ± 25  
Creatinine 0.82 ± 0.2  
 
Table S1.  Characteristics of the donors of cells (saphenectomy) and tissues (CABG surgery) collected for 
the study. Data are presented as percentages or mean ± SD.  
 
24h stimulation 
Description t-test FC (ON/OFF) Peptide count 
Unique 
peptides 
Confidence 
score 
Thrombospondin-1 0.039 1.31 5 5 26.4 
Cathepsin L1 0.062 0.89 1 1 6.3 
Glia-derived nexin 0.076 0.66 4 4 23.8 
Collagen alpha-3(VI) 0.077 0.85 8 7 37.5 
Actin_ cytoplasmic 1 0.085 1.10 3 3 17.4 
Histone H2B type 1-K 0.11 1.20 1 1 6.6 
Pentraxin-related protein 
PTX3 0.12 1.25 2 2 12.6 
72 kDa type IV collagenase 0.13 0.75 2 2 10.9 
Tenascin-X  0.167 1.49 3 3 15.3 
Metalloproteinase 
inhibitor 1 0.19 0.64 3 3 20.4 
Collagen alpha-1(III) 
chain 0.23 0.90 6 6 30.5 
Transforming growth 
factor-beta-induced 
protein ig-h3 
0.26 0.83 3 3 18.2 
Galectin-3-binding protein 0.28 0.94 1 1 5.6 
SPARC OS=Homo sapiens 0.30 1.11 3 3 16.8 
Collagen alpha-1(VI) chain 0.37 1.09 6 6 31.2 
Fibronectin 0.42 0.95 53 52 432.4 
Collagen alpha-1(I) chain 0.45 0.91 29 7 194.3 
Collagen alpha-1(II) chain 0.52 0.95 6 2 26.9 
Decorin 0.61 1.03 6 6 32.9 
Vimentin 0.67 1.06 6 6 32.1 
Collagen alpha-2(I) chain 0.74 0.95 32 13 212.2 
Collagen alpha-2(VI) chain 0.93 1.02 1 1 4.9 
 
  
72h stimulation 
Description t-test FC (ON/OFF) Peptide count 
Unique 
peptides 
Confidence 
score 
Collagen alpha-1(VI) chain 0.009 0.82 24 23 195.6 
Pigment epithelium-derived 
factor 0.013 0.87 6 6 37.7 
Thrombospondin-1 0.029 1.99 21 20 154.8 
SPARC 0.030 1.20 6 6 48.7 
Fibronectin 0.042 0.68 79 37 779.8 
Cartilage oligomeric matrix 
protein 0.043 0.82 7 7 69.1 
Collagen alpha-3(VI) chain 0.05 0.71 22 20 122.3 
Target of Nesh-SH3 0.079 0.70 5 5 34.3 
Decorin 0.091 0.77 11 9 71.2 
Fibrillin-1 0.095 0.86 4 4 24.8 
Collagen alpha-1(III) chain 0.12 0.83 44 35 332.4 
Collagen alpha-2(VI) chain 0.13 0.90 14 12 82.5 
Collagen alpha-1(I) chain 0.15 1.14 75 11 621.6 
72 kDa type IV collagenase 0.19 0.84 6 6 42.7 
Transforming growth factor-
beta-induced protein ig-h3 0.19 0.71 8 8 49.1 
Complement C1s 
subcomponent 0.24 0.87 6 6 38.8 
Metalloproteinase inhibitor 2 0.28 0.77 2 2 18.8 
L-lactate dehydrogenase A 
chain 0.28 0.92 6 5 36.9 
Biglycan 0.41 1.20 6 4 42.1 
Vimentin 0.41 1.09 19 18 125.8 
Lumican 0.44 0.91 9 9 75.0 
Galectin-3-binding protein 0.44 0.87 6 5 39.4 
Lactadherin 0.59 0.93 4 3 23.0 
Metalloproteinase inhibitor 1 0.59 0.94 6 6 48.2 
Glia-derived nexin 0.73 1.08 11 11 75.6 
Clusterin 0.74 1.04 9 9 71.0 
Pentraxin-related protein PTX3 0.75 1.04 9 9 64.2 
Follistatin-related protein 1 0.79 1.02 5 5 28.3 
Collagen alpha-2(I) chain 0.87 1.01 67 34 584.3 
Collagen alpha-1(XII) chain 0.92 1.01 28 25 172.8 
Insulin-like growth factor-
binding protein 7 0.93 0.99 8 7 62.4 
Tenascin-X 0.95 0.99 29 27 171.9 
 
Tables S2. Results of mass spectrometry-based secretome analysis on SMCs stimulated mechanically for 24 
(n = 3) and 72 (n = 6) h. In red and green colors, respectively, are indicated secreted proteins with a significantly 
(P < 0.05; paired t-test) increased or decreased secretion in conditioned medium. Note the presence of 
Thrombospondin-1 as the unique factor secreted in higher amounts in mechanically stimulated SMCs vs. 
Controls at both time points.  
 
Antibody/ 
Reagent 
Host Manufacturer Clone, product code Concentration 
tissue/cells 
αSMA Mouse Dako 1A4, M0851 142 ng/mL tissue,  700 ng/mL cells 
Calponin Mouse Abcam PC10, ab65827 500 ng/mL tissue 
CD44 Rat Abcam IM7, ab119863 20 μg/mL tissue 
SM22α Rabbit Abcam Polyclonal, ab14106 1.4 μg/mL tissue,  8 μg/mL cells 
PCNA Mouse Dako PC10, M0879 1.64 μg/mL tissue, 3.27 μg/mL cells 
TSP-1 Mouse Invitrogen A6.1, MA5-13398 2 μg/mL tissue 
TPM4 Mouse Bio-Rad 4A4-1D2, MCA5263Z 5 μg/mL 
Vimentin Rabbit Cell signaling technology D21H3, #5741 Diluted as indicated 
PDGFRβ Rabbit Cell Signaling Technology 28E1, #3169 Diluted as indicated 
Vinculin Rabbit Invitrogen 42H89L44 5 μg/mL 
Phalloidin - Sigma Aldrich P1951 32 μg/mL 
DAPI - Dako D1306 50 μg/mL 
488 mouse Donkey Invitrogen A11034 4 μg/mL 
488 rabbit Goat Invitrogen A11034 4 μg/mL 
546 mouse Donkey Invitrogen A10036 4 μg/mL 
546 rat Goat Invitrogen A11081 4 μg/mL 
546 rabbit Goat Invitrogen A11010 4 μg/mL 
Table S3. Reagents, primary and secondary antibodies employed for tissue and cell IF analysis. 
 
Antibody Host Manufacturer Concentration 
αSMA Mouse Dako 7 μg/mL 
Vimentin Rabbit Cell signaling technology Diluted as indicated 
TSP-1 Mouse Invitrogen 200 ng/mL 
SM22α Rabbit Abcam 1 μg/mL 
GAPDH Mouse/Rabbit Santa-Cruz 200 ng/mL 
680 anti-mouse Donkey LI-COR 100 ng/mL 
680 anti-rabbit Donkey LI-COR 100 ng/mL 
800 anti-mouse Donkey LI-COR 100 ng/mL 
800 anti-rabbit Donkey LI-COR 100 ng/mL 
Table S4. List of primary and secondary antibodies used for Western Blot.  
 
Gene Sequence 
hTSP-1 Forward: 5’-TGAGGAGGACACTGGTAGAG-3’ Reverse: 5’-GGGCCTCAATGACAATTTCC-3’ 
hTAGLN Forward: 5’-ACAAACTCATCTTCCTCAAGCC-3’ Reverse: 5’-CTTCTCATTTTCCATTCCCTTCAC-3’ 
hCOL1A1 Forward: 5’-GGACACAGAGGTTTCAGTGG -3’ Reverse: 5’-CCAGTAGCACCATCATTTCC -3’ 
hTGFβ-R Forward: 5’-GCCAGTCCTAAGTCTGCAAT-3’ Reverse: 5’-GGTCTTGCCCATCTTCACA-3’ 
hGAPDH Forward: 5’-AATCCCATCACCATCTTCCAG-3’ Reverse: 5’-AAATGAGCCCCAGCCTTC-3’ 
Table S5. PCR oligo sequences of primers employed in Q-RT-PCR analysis 
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